GlaxoSmithKline plc (ADR) – $GSK – Confident Investor Rating:Fair
2009-12-18
| Company name | GlaxoSmithKline plc (ADR) |
| Stock ticker | GSK |
| Live stock price | [stckqut]GSK[/stckqut] |
| P/E compared to competitors | Good |
| Employee productivity | Good |
| Sales growth | Poor |
| EPS growth | Poor |
| P/E growth | Good |
| EBIT growth | Poor |
| Confident Investor Rating | Fair |
| Target stock price (TWCA growth scenario) | $78.12 |
| Target stock price (averages with growth) | $105.32 |
| Target stock price (averages with no growth) | $51.43 |
| Target stock price (manual assumptions) | $32.44 |
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.